Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Losartan effects on metabolic parameters in hypertensive patients with metabolic syndrome
NCT00546052Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Sep 2005
- Primary completion
- Jan 2008
- Modality
- Small Molecules
01
Overview
Phase 3, open-label, single-arm trial of losartan in hypertension (HTN), sponsored by Organon & Co. Primary endpoints: Change in Hemoglobin A1c at 52 weeks and Change in Fasting Blood Glucose at 52 weeks. Started Sep 2005; status: completed.
02
Drugs
losartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00546052.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00546052.